GNI Group (F351 Program) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Asset Purch.

  • Financing Rounds
  • 1

GNI Group (F351 Program) General Information

Description

Portfolio of advanced liver fibrosis drug development in Tokyo, Japan.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Nihonbashi-Honcho YS Building 3rd Floor
  • 2-2-2 Nihonbashi-Honcho, Chuo-ku
  • Tokyo, 103-0023
  • Japan
Primary Industry
Buildings and Property
Other Industries
Drug Discovery
Corporate Office
  • Nihonbashi-Honcho YS Building 3rd Floor
  • 2-2-2 Nihonbashi-Honcho, Chuo-ku
  • Tokyo, 103-0023
  • Japan

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

GNI Group (F351 Program) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore GNI Group (F351 Program)‘s full profile, request access.

Request a free trial

GNI Group (F351 Program) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore GNI Group (F351 Program)‘s full profile, request access.

Request a free trial

GNI Group (F351 Program) FAQs

  • Where is GNI Group (F351 Program) headquartered?

    GNI Group (F351 Program) is headquartered in Tokyo, Japan.

  • What industry is GNI Group (F351 Program) in?

    GNI Group (F351 Program)’s primary industry is Buildings and Property.

  • Is GNI Group (F351 Program) a private or public company?

    GNI Group (F351 Program) is a Private company.

  • What is the current valuation of GNI Group (F351 Program)?

    The current valuation of GNI Group (F351 Program) is .

  • What is GNI Group (F351 Program)’s current revenue?

    The current revenue for GNI Group (F351 Program) is .

  • Who are GNI Group (F351 Program)’s investors?

    GNI Group has invested in GNI Group (F351 Program).

  • When was GNI Group (F351 Program) acquired?

    GNI Group (F351 Program) was acquired on 15-Feb-2023.

  • Who acquired GNI Group (F351 Program)?

    GNI Group (F351 Program) was acquired by Gyre Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process